Literature DB >> 23692088

Character comparison of abdomen-derived and eyelid-derived mesenchymal stem cells.

S-H Kim1, S H Bang, S A Park, S Y Kang, K D Park, I U Oh, S H Yoo, H Kim, C-H Kim, S Y Baek.   

Abstract

OBJECTIVES: While most human adipose tissues, such as those located in the abdomen, hip and thigh, are of mesodermal origin, adipose tissues located in the face are of ectodermal origin. The present study has compared stem cell-related features of abdomen-derived adult stem cells (A-ASCs) with those of eyelid-derived adult stem cells (E-ASCs).
MATERIALS AND METHODS: Adipose tissue-derived cells were maintained in DMEM supplemented with 10% FBS. Before passage 6, cells were analysed using FACS, immunocytochemistry and quantitative real time PCR (qRT-PCR). To examine multi-differentiational potential, early passage ASCs were cultivated in each of a commercial Stempro(®) Differentiation kit.
RESULTS: Unlike fibroblast-like morphology of A-ASCs, E-ASCs had bipolar morphology. Both types of cell exhibited similar surface antigens, and neuronal cell-related genes and proteins. However, there were differences in mRNA expression levels of CD90 and CD146; neuron-specific enolase (NSE) and nuclear receptor-related protein 1 (Nurr1) were different between the two cell types. There was no difference in multi-differentiational potential between 3 E-ASCs lines, however, E-ASCs had higher expression levels of chondrocyte-related genes compared to A-ASCs. These cells underwent senescence and maintained normal karyotypes.
CONCLUSIONS: Although isolated from similar adipose tissues, both types of cells displayed many contrasting characteristics. Understanding defining phenotypes of such cells is useful for making suitable choices in differing clinical indications.
© 2013 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23692088      PMCID: PMC6496585          DOI: 10.1111/cpr.12027

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  34 in total

1.  Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

Authors:  E M Horwitz; K Le Blanc; M Dominici; I Mueller; I Slaper-Cortenbach; F C Marini; R J Deans; D S Krause; A Keating
Journal:  Cytotherapy       Date:  2005       Impact factor: 5.414

2.  Characterization and isolation of stem cell-enriched human hair follicle bulge cells.

Authors:  Manabu Ohyama; Atsushi Terunuma; Christine L Tock; Michael F Radonovich; Cynthia A Pise-Masison; Steven B Hopping; John N Brady; Mark C Udey; Jonathan C Vogel
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

3.  Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers.

Authors:  James B Mitchell; Kevin McIntosh; Sanjin Zvonic; Sara Garrett; Z Elizabeth Floyd; Amy Kloster; Yuan Di Halvorsen; Robert W Storms; Brian Goh; Gail Kilroy; Xiying Wu; Jeffrey M Gimble
Journal:  Stem Cells       Date:  2005-12-01       Impact factor: 6.277

Review 4.  Fat tissue: an underappreciated source of stem cells for biotechnology.

Authors:  John K Fraser; Isabella Wulur; Zeni Alfonso; Marc H Hedrick
Journal:  Trends Biotechnol       Date:  2006-02-20       Impact factor: 19.536

5.  Downregulation of extracellular matrix-related gene clusters during osteogenic differentiation of human bone marrow- and adipose tissue-derived stromal cells.

Authors:  Hiroshi Egusa; Keisuke Iida; Munemasa Kobayashi; Terry Y Lin; Min Zhu; Patricia A Zuk; Chiachien Jake Wang; Devang K Thakor; Marc H Hedrick; Ichiro Nishimura
Journal:  Tissue Eng       Date:  2007-10

Review 6.  Adipose-derived stem cells for regenerative medicine.

Authors:  Jeffrey M Gimble; Adam J Katz; Bruce A Bunnell
Journal:  Circ Res       Date:  2007-05-11       Impact factor: 17.367

7.  Identification of novel epithelial stem cell-like cells in human deciduous dental pulp.

Authors:  Hyun Nam; Gene Lee
Journal:  Biochem Biophys Res Commun       Date:  2009-06-06       Impact factor: 3.575

8.  Multilineage cells from human adipose tissue: implications for cell-based therapies.

Authors:  P A Zuk; M Zhu; H Mizuno; J Huang; J W Futrell; A J Katz; P Benhaim; H P Lorenz; M H Hedrick
Journal:  Tissue Eng       Date:  2001-04

9.  Phenotypic characterization of distinct human bone marrow-derived MSC subsets.

Authors:  Hans-Jörg Bühring; Sabrina Treml; Flavianna Cerabona; Peter de Zwart; Lothar Kanz; Malgorzata Sobiesiak
Journal:  Ann N Y Acad Sci       Date:  2009-09       Impact factor: 5.691

10.  Insulin-secreting cells from human eyelid-derived stem cells alleviate type I diabetes in immunocompetent mice.

Authors:  Hyun Mi Kang; Jiyoung Kim; Seah Park; Jinyoung Kim; Haekwon Kim; Kyung Sik Kim; Eun Jig Lee; Sung Ig Seo; Sung Goo Kang; Jong-Eun Lee; Hyunjung Lim
Journal:  Stem Cells       Date:  2009-08       Impact factor: 6.277

View more
  4 in total

1.  Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop.

Authors:  Lan G Coffman; Yun-Jung Choi; Karen McLean; Benjamin L Allen; Marina Pasca di Magliano; Ronald J Buckanovich
Journal:  Oncotarget       Date:  2016-02-09

2.  Human eyelid adipose tissue-derived Schwann cells promote regeneration of a transected sciatic nerve.

Authors:  Gangyang Wang; Lingling Cao; Yang Wang; Yingqi Hua; Zhengdong Cai; Jun Chen; Lulu Chen; Yuqing Jin; Lina Niu; Hua Shen; Yan Lu; Zunli Shen
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

3.  Comparative Analysis of Human Adipose-Derived Mesenchymal Stem Cells from Orbital and Abdominal Fat.

Authors:  Sarmila Nepali; Mira Park; Helen Lew; Okjoon Kim
Journal:  Stem Cells Int       Date:  2018-08-19       Impact factor: 5.443

4.  The Effect of Age on the Regenerative Potential of Human Eyelid Adipose-Derived Stem Cells.

Authors:  Mingqi Zhang; Zhuoshi Wang; Yan Zhao; Lirong Zhang; Ling Xu; Liu Cao; Wei He
Journal:  Stem Cells Int       Date:  2018-03-19       Impact factor: 5.443

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.